Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era-Reference-Cited by-同舟云学术

Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era

Published:2014-10-14 Issue:5 Volume:168 Page:654-662
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ferreri Andrés J. M.¹,Bruno-Ventre Marta¹,Donadoni Giovanni¹,Ponzoni Maurilio¹²,Citterio Giovanni¹,Foppoli Marco¹,Vignati Alessandro¹,Scarfò Lydia¹,Sassone Marianna¹,Govi Silvia¹,Caligaris-Cappio Federico¹

Affiliation:

1. Division of Onco-Haematological Medicine; Department of Onco-Haematology; Unit of Lymphoid Malignancies; Milan Italy

2. Pathology Unit; San Raffaele Scientific Institute; Milan Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13194/fullpdf

Reference24 articles.

1. Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma;Abramson;Cancer,2010

2. Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: an analysis of 3,258 patients in a single center;Aviles;Medical Oncology,2013

3. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up;Bjorkholm;Annals of Oncology,2007

4. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma-a survey of 1693 patients treated in protocols of the german high-grade non-hodgkin's lymphoma study group (DSHNHL);Boehme;Annals of Oncology,2007

5. Report of the committee on hodgkin's disease staging classification;Carbone;Cancer Research,1971

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system prophylaxis in large B‐cell lymphoma: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-08-11

2. Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphoma;Pathology - Research and Practice;2024-08

3. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma;JCO Oncology Practice;2024-06

4. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma;Blood Advances;2024-03-18

5. Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601;Annals of Hematology;2024-01-27